Loading…
← CockpitCompetitor Analysis › AMN AMN Healthcare Services, Inc.Open in the cockpit ↗

AMN Healthcare Services, Inc.AMNCompetitor analysis, valuation and peers

United States · USD·Health Care›Personnel Services

Staffs hospitals with travel nurses, physicians and allied health professionals, plus workforce-scheduling software.

Momentum leader 83
Mkt cap
$1.45B
US dollars, full cap
Free float
99%
of shares outstanding
$/day
$38.9M
20-day average traded
Fwd P/E
40.8×
forward earnings
ROIC−WACC
+5.9 pp
WACC 6.6%
Hurdle
-13 pp
Req g minus delivered
Next earnings
92 days
18 Feb 2027
Close · USD$37.60
1D-1.3%
1W-0.8%
1M-9.7%
3M+8.1%
6M+40.0%
YTD+138.6%
1Y+136.5%
ATR %6.0%
Beta0.57
52w lowhigh24.2% off high

What AMN Healthcare Services does

Staffs hospitals with travel nurses, physicians and allied health professionals, plus workforce-scheduling software.

Bills hospitals an hourly rate for each clinician placed and pays the clinician less, so results depend on how many contract shifts hospitals buy and on the gap between the two rates. Nurse staffing carries the company, with physician placement next. Its software lets a hospital run several outside staffing agencies from one system.

Products and services

  • Travel nurse staffing
  • Locum tenens physician staffing
  • Vendor management software (VMS)

Customers

  • Hospitals and health systems

Where it sits in the supply chain

  • Healthcare staffing services
  • Travel nurse/locum tenens placement
  • Workforce management technology

What could go right

  • Persistent hospital nurse shortages
  • Cross-sell technology/managed services

What could go wrong

  • Post-COVID travel-nurse rate normalization
  • Hospital cost-cutting on contract labor

Moat: narrow (scale, installed base). Large clinician networks and hospital VMS contracts give an edge over smaller staffing rivals.

Headquarters: Dallas, Texas, US · Founded: 1985 · Employees: 2,664

Named competitors

  • Cross Country Healthcare private or unlisted
  • Aya Healthcare private or unlisted
  • ShiftKey private or unlisted
  • Trusted Health private or unlisted

AMN Healthcare Services at a glance

Size AMN Healthcare Services (AMN) is a United States Health Care company (Personnel Services) with a market value of $1.45B, the 1991st largest of 3,085 United States companies the cockpit tracks. Shares closed at $37.60 on 18 Nov 2026.

Performance Over six months the shares gained 40.0%, against -5.9% for the median peer and -2.2% for the United States market (cap-weighted) — 4th highest of 21 in its peer set.

Growth Revenue grew 29.4% over the last twelve months (peer median +13.0%); the operating margin is 5.8% (peer median -3.5%).

Valuation It trades at 40.8× forward earnings against a peer median of 13.5× (most expensive of 9).

Price implies For today's price to make sense, revenue must grow about -11% a year for seven years (Req g). Recent delivered growth is +3%, so the hurdle is -13 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 5.9 points above its cost of capital (6.6% WACC).

Short interest Short interest is 11.1% of the free float (30 Oct 2026).

Next results Next results expected around 18 Feb 2027 (exchange calendar; dates can move).

Relative performance

10015021 May 202621 Aug 202618 Nov 2026AMN 147Peer median 92
Six months, rebased to 100: AMN Healthcare Services against the median of its 20 peers (local-currency closes).

AMN Healthcare Services financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$3.52B$2.73B$2.98B$3.79B$5.24B
Revenue growth—-8%-21%-28%—
Gross profit$870M$626M$752M$1.09B$1.58B
EBITDA$342M$190M$294M$502M$781M
Net income$109M-$95.7M-$147M$211M$444M
Free cash flow$327M$234M$240M$268M$578M
Capital expenditure$34.0M$35.6M$80.9M$105M$80.9M
Total debt$775M$803M$1.10B$1.35B$861M

Quarterly statements and history in the cockpit →

AMN Healthcare Services competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-25%0%+25%+50%-40%-20%0%+20%PRCTPAHCURGNIMCRTDOCCNMDASTHUSPHQUREDMRAABSIALHCANABKRSARAPPAGLKLRAPGENNTLANRIXAMN6-month return →1-month return →
Up and to the right = strong over both horizons. AMN Healthcare Services is the large dot.

Fundamentals: revenue growth against valuation

0%+1,000%+2,000%20×40×PAHCURGNCNMDASTHUSPHANABAGLPGENAMNRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. AMN Healthcare Services is the large dot.

Capital: growth delivered against growth the price implies

0%+20%0%20%PAHCTDOCCNMDASTHUSPHALHCANABAMNGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. AMN Healthcare Services is the large dot.

AMN Healthcare Services competitors and peer comparison

How AMN Healthcare Services compares with its peers

Peer set: Sector in the same market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

AMN Healthcare Services against its 20 peers (data as of 18 Nov 2026)
MeasureAMNPeer medianRank in peer set
1-month return-9.7%-9.2%11th highest of 21
6-month return+40.0%-5.9%4th highest of 21
Distance from 52-week high-24.2%-41.1%4th highest of 21
Revenue growth (TTM)+29.4%+13.0%6th highest of 18
Operating margin5.8%-3.5%6th highest of 19
Forward P/E40.8×13.5×most expensive of 9
Growth the price implies (Req g, 7 yrs)-10.6%7.4%least demanding of 8
Growth delivered (Del g)+2.7%+18.3%lowest of 8
Hurdle (Req g minus delivered)-13.3 pp-20.5 pp3rd most demanding of 8
ROIC minus cost of capital+5.9 pp-12.7 pp4th highest of 13
EV / EBITDA5.7×12.4×2nd cheapest of 8
Net debt / EBITDA1.5×2.1×5th least indebted of 9

Peer table

Peer set: Sector in the same market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
AMN Healthcare Services AMNUnited States$1.45B+40%+29%6%40.8×-10.6%+2.7%
PROCEPT BioRobotics PRCTUnited States$1.45B-10%+17%-34%n/an/an/a
Phibro Animal Health PAHCUnited States$1.44B+5%+10%13%9.9×-6.4%+12.7%
UroGen Pharma URGNUnited States$1.46B-1%+159%-12%16.7×n/an/a
Immunocore Holdings Plc Shs Sponsored American Depositary Shares Repr 1 Sh IMCRUnited States$1.44B-7%+13%-7%n/an/an/a
Teladoc Health TDOCUnited States$1.47B+24%-2%-5%n/a-6.4%+18.3%
CONMED CNMDUnited States$1.43B+30%+2%2%10.4×31.6%+9.8%
Astrana Health ASTHUnited States$1.47B-24%+35%3%17.6×7.4%+35.9%
U.S. Physical Therapy USPHUnited States$1.42B+53%+10%10%29.4×18.8%+13.0%
uniQure QUREUnited States$1.42B-17%+28%-1,027%n/an/an/a
Damora Therapeutics DMRAUnited States$1.42B-5%n/an/an/an/an/a
Absci ABSIUnited States$1.41B+65%-47%-9,155%n/an/an/a
Alignment Healthcare ALHCUnited States$1.41B-60%+36%1%n/a12.2%+32.7%
AnaptysBio ANABUnited States$1.40B-22%+13%62%4.9×0.5%+25.6%
Korsana Biosciences KRSAUnited States$1.52B+54%-64%-5,277%n/an/an/a
Rapport Therapeutics RAPPUnited States$1.39B-34%n/a-838%n/an/an/a
agilon health AGLUnited States$1.52B+12%+2%-2%34.1×n/an/a
Kailera Therapeutics KLRAUnited States$1.53B-41%n/an/an/an/an/a
Precigen PGENUnited States$1.53B0%+2,388%21%7.3×n/an/a
Intellia Therapeutics NTLAUnited States$1.37B-20%-8%-821%n/an/an/a
Nurix Therapeutics NRIXUnited States$1.54B-14%+739%41%n/an/an/a

Questions

Who are AMN Healthcare Services's main competitors?
Named competitors: Cross Country Healthcare (private or unlisted), Aya Healthcare (private or unlisted), ShiftKey (private or unlisted), Trusted Health (private or unlisted). The cockpit's measured peer set (sector in the same market, nearest in size) also includes PROCEPT BioRobotics (PRCT), Phibro Animal Health (PAHC), UroGen Pharma (URGN), Immunocore Holdings Plc Shs Sponsored American Depositary Shares Repr 1 Sh (IMCR), Teladoc Health (TDOC), CONMED (CNMD).
Is AMN Healthcare Services expensive compared with its peers?
On forward p/e it trades at 40.8× against a peer median of 13.5×, most expensive of 9 in its peer set. For today's price to make sense, revenue must grow about -11% a year for seven years (Req g). Recent delivered growth is +3%, so the hurdle is -13 pp: the price already allows for a slowdown.
How has AMN Healthcare Services stock performed?
Over six months to 18 Nov 2026 the shares returned +40.0% against -5.9% for the median peer; over one year +136.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.